Kinetin Riboside

Kinetin Riboside

SCHEMBL14713468

OC[C@H]1O[C@@H](n2cnc3c(NCc4ccco4)ncnc32)[C@@H](O)C1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 6/20 1.00
▸ SLC29A1 Q99808 4/20 1.00
▸ TP53 P04637 3/20 1.00
▸ PAX8 Q06710 3/20 1.00
▸ SMN1; SMN2 Q16637 1/20 1.00
▸ MITF O75030 1/20 1.00
▸ LMNA P02545 1/20 1.00
▸ TDP1 Q9NUW8 1/20 0.74
▸ ADORA2A P29274 3/20 0.69
▸ ADORA1 P30542 3/20 0.69
▸ TSHR P16473 1/20 0.69
▸ NFKB1 P19838 1/20 0.69
▸ STAT6 P42226 1/20 0.69
▸ GMNN O75496 1/20 0.69
▸ BLM P54132 1/20 0.69
▸ PMP22 Q01453 1/20 0.69
▸ ADORA2B P29275 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Kinetin Riboside SCHEMBL217034 1.00 ADORA3 (1.00) ADORA3SLC29A1TP53PAX8SMN1; SMN2
Kinetin Riboside SCHEMBL17825970 1.00 ADORA3 (1.00) ADORA3SLC29A1TP53PAX8SMN1; SMN2
Kinetin Riboside SCHEMBL29564117 1.00 ADORA3 (1.00) ADORA3SLC29A1TP53PAX8SMN1; SMN2
Kinetin Riboside SCHEMBL3339041 1.00 ADORA3 (1.00) ADORA3SLC29A1TP53PAX8SMN1; SMN2
Kinetin Riboside SCHEMBL3190252 1.00 ADORA3 (1.00) ADORA3SLC29A1TP53PAX8SMN1; SMN2
Kinetin Riboside SCHEMBL14713232 1.00 ADORA3 (1.00) ADORA3SLC29A1TP53PAX8SMN1; SMN2
Kinetin Riboside SCHEMBL3190271 1.00 ADORA3 (1.00) ADORA3SLC29A1TP53PAX8SMN1; SMN2
Kinetin Riboside SCHEMBL19583061 1.00 ADORA3 (1.00) ADORA3SLC29A1TP53PAX8SMN1; SMN2
SCHEMBL25170466 0.99 ADORA3 (0.98) ADORA3SLC29A1TP53PAX8SMN1; SMN2
SCHEMBL29697393 0.99 ADORA3 (0.98) ADORA3SLC29A1TP53PAX8SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130045942-A1 N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2013-02-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130045942-A1 N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF ADORA2A, ADORA3, ADORA1 ADORA3 2/4885SLC29A1 267/4885TP53 3945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback